18 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
5 May 23
Departure of Directors or Certain Officers
4:59pm
personal relief based on any claim, cause of action, demand, lawsuit or similar that is waived pursuant to this Agreement and brought by you or on your … , lawsuit or similar that is waived pursuant to the Agreement or Supplemental Release and brought by you or on your behalf by any third party, including
8-K
EX-10.1
4q7hqspdja8gw7vw3pc
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
8-K
EX-1.1
c8ym8rxzk
23 Jan 19
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
5:05pm
10-K
zy3ua oub
31 Mar 15
Annual report
12:00am
424B4
8pwupnh jbhsqymtjw
13 Feb 15
Prospectus supplement with pricing info
12:00am
S-1
2y13n667f49dksso
13 Jan 15
IPO registration
12:00am
DRS/A
2p9ps6aa
21 Nov 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next